日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A New Simulation Method to Assess Temperature and Radiation Effects on SiC Resonant-Converter Reliability

一种评估温度和辐射对SiC谐振转换器可靠性影响的新仿真方法

期刊:Materials
影响因子:3.2
doi:10.3390/ma19020228
Feng, Zhuowen; Lai, Pengyu; Hasan, Abu Shahir Md Khalid; Fatani, Fuad; Alaeddini, Alborz; Huang, Liling; Chen, Zhong; Li, Qiliang
发表日期：2026
文献求助 收藏

Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000-2025)

过去26年（2000-2025年）免疫检查点抑制剂在实体瘤和淋巴瘤治疗中的应用

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01734-x
Huang, Liling; Zhu, Haohua; Shi, Yuankai
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer

预测非小细胞肺癌一线化疗-免疫治疗生存率和长期疗效的临床、免疫细胞和遗传特征

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04022-2
Huang, Liling; Zhu, Haohua; Dai, Liyuan; Feng, Yu; Chen, Xinrui; Xie, Zucheng; Hu, Xingsheng; Liu, Yutao; Hao, Xuezhi; Lin, Lin; Wang, Hongyu; Zhou, Shengyu; Yao, Jiarui; Tang, Le; Han, Xiaohong; Shi, Yuankai
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer.

多组学揭示 BCAA 代谢标志物 L-亮氨酸和 HMGCS1 可作为非小细胞肺癌免疫疗法疗效的预后标志物

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-025-03277-8
Dai Liyuan, Wang Xinzheng, Lou Ning, Li Lin, Huang Liling, Tang Le, Yao Jiarui, Shi Yuankai, Han Xiaohong
代谢
肺癌
发表日期：2025
文献求助 收藏

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer.

揭示 HDAC3 在晚期非小细胞肺癌中作为免疫治疗预后生物标志物和治疗靶点的作用

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-025-03275-w
Dai Liyuan, Huang Liling, Li Lin, Tang Le, Shi Yuankai, Han Xiaohong
细胞生物学
肺癌
发表日期：2025
文献求助 收藏

Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell lung cancer patients undergoing immunotherapy.

治疗前血浆 sCD14 作为接受免疫治疗的晚期非小细胞肺癌患者的预后指标

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14148-2
Dai Liyuan, Huang Liling, Li Lin, Tang Le, Yao Jiarui, Shi Yuankai, Han Xiaohong
细胞生物学
肺癌
CD14
发表日期：2025
文献求助 收藏

Pharmacological Intervention for Refractory Biofilm Infection After Hemipelvic Replacement Surgery: Multidisciplinary Management of a Case of Giant Cell Tumor of Bone

半骨盆置换术后难治性生物膜感染的药物干预：骨巨细胞瘤病例的多学科管理

期刊:American Journal of Case Reports
影响因子:0.7
doi:10.12659/AJCR.949210
Huang, Liling; Wang, Linyu; Nong, Hao; Liu, Bin; Li, Yan
炎症/感染
细胞生物学
微生物学
发表日期：2025
文献求助 收藏

Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma

针对复发/难治性弥漫性大B细胞淋巴瘤患者，采用含PD-1单克隆抗体方案进行多组学分析和疗效预测

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03840-0
Chen, Xinrui; Qin, Yan; Xue, Xuemin; Xie, Zucheng; Xie, Tongji; Huang, Liling; Zhu, Haohua; Gao, Lina; Li, Jiangtao; Yang, Jianliang; Gui, Lin; Yang, Sheng; Chen, Haizhu; Feng, Xiaoli; Shi, Yuankai
单克隆抗体
B细胞
淋巴瘤
细胞生物学
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏

Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer

III-IV期肺大细胞神经内分泌癌和小细胞肺癌的发病率、生存率比较及新的预后评估方法

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-10797-3
Huang, Liling; Feng, Yu; Xie, Tongji; Zhu, Haohua; Tang, Le; Shi, Yuankai
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Ganoderma lingzhi culture enhance growth performance via improvement of antioxidant activity and gut probiotic proliferation in Sanhuang broilers

灵芝培养物通过提高抗氧化活性和促进肠道益生菌增殖来增强三黄肉鸡的生长性能

期刊:Frontiers in Veterinary Science
影响因子:2.9
doi:10.3389/fvets.2023.1143649
Liu, Xuzhou; Huang, Liling; Shi, Yan; Wang, Xiaoguo; Luo, Yanglan; Wei, Shiyan; Qin, Yanchun; Lu, Yuwen; Zhang, Wenlong; Ju, Ying; Yan, Yong; Liao, Yuying
发表日期：2023
文献求助 收藏